First human-like COVID-19 mouse model created
On Nov. 6, 2023, researchers at NYU Grossman School of Medicine announced they had engineered the first mice…
-
-
Novavax’s updated COVID-19 vaccine approved in the EU
On Oct. 31, 2023, Novavax announced that the European Commission had granted approval for Nuvaxovid XBB.1.5 dispersion for…
-
Novavax received full Marketing Authorization for potype COVID-19 vaccine Nuvaxovid in UK
On Oct. 18, 2023, Novavax announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…
-
Novavax’s prototype COVID-19 vaccine Nuvaxovid received full approval in Singapore
On Oct. 18, 2023, Novavax announced that Singapore’s Health Sciences Authority (HSA) had granted full approval for Novavax’s…
-
The U.S. Strategic National Stockpile was not positioned to respond effectively to the COVID-19 Pandemic
On Oct. 16. 2023, the U.S. Dept. of Health and Human Services reported results of an audit that…
-
Biotechnology | CDC | COVID-19 | FDA | Infectious Disease | Vaccine
Novavax 2023-2024 COVID-19 Vaccine Authorized and Recommended for Use in the U.S.
On Oct. 3, 2023, Novavax announced that it’s COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) (NVX-CoV2601) had received Emergency Use…
-
Vir Biotechnology awarded BARDA funding to support development of antibody platform technologies for global infectious disease threats
On Oct. 3, 2023, Vir Biotechnology announced that the Biomedical Advanced Research and Development Authority (BARDA), part of…
-
FDA authorized updated Novavax COVID-19 vaccine formulated to better protect against currently circulating variant
On Oct. 3, 2023, the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) of…
-
COVID-19 | CRISPR | Therapeutics | Vaccine
Nobel Prize in medicine was jointly awarded to Katalin Kariko and Drew Weissman “for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19”
On Oct. 2, 2023, the Nobel Prize in Physiology or medicine was awarded jointly to Katalin Kariko and…
-
WHO recommended R21/Matrix-M vaccine for malaria prevention
On Oct. 2, 2023, the World Health Organization (WHO) announced it had recommended a new vaccine, R21/Matrix-M, developed…
-
Pfizer and BioNTech received Health Canada authorization for XBB.1.5-adapted monovalent COVID-19 vaccine
On Sept. 28, 2023, Pfizer and BioNTech that Health Canada had authorized the companies’ Omicron XBB.1.5-adapted monovalent COVID-19…
-
SARS-CoV-2 infects coronary arteries, increases plaque inflammation
On Sept. 28, 2023, the National Institute of health announced SARS-CoV-2, the virus that causes COVID-19, can directly…
-
Gritstone Bio awarded $433 Mmillion BARDA contract to conduct comparative phase 2b study evaluating next-generation vaccine candidate for COVID-19
On Sept. 27, 2023, Gritstone bio announced that it was awarded a contract by the Biomedical Advanced Research…
-
New cancer diagnoses fell abruptly early in the COVID-19 pandemic according to Annual Report to the Nation
On Sept. 27, 2023, the U.S. Centers for Disease Control and Prevention (CDC) reported that new diagnoses of…
-
Moderna received U.S. FDA approval for updated COVID-19 vaccine
On Sept. 11, 2023, Moderna announced the U.S. Food and Drug Administration (FDA) had approved the supplemental Biologics…
-
Pfizer and BioNTech received U.S. FDA approval for 2023-2024 COVID-19 vaccine
On Sept. 11, 2023, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) approved the…
-
Moderna clinical trial data confirmed updated Covid-19 vaccine generated strong immune response against BA.2.86 variant
On Sept. 6, 2023, Moderna announced that clinical trial data from its research assay confirmed its updated COVID-19…
-
COVID-19 | FDA | Infectious Disease | Vaccine
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
On Aug. 30, 2023, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
-
WHO initiative signed new licensing agreements on COVID-19 technologies
On Aug. 29, 2023, the COVID-19 Technology Access Pool (C-TAP), a multi-stakeholder partnership to facilitate sharing of intellectual…
-
CDC reported risk assessment summary for SARS CoV-2 sublineage BA.2.86
On Aug. 23, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced 9 BA.2.86 variant sequences…
-
Project NextGen awarded over $1.4 billion to develop future of COVID-19 vaccines and therapeutics
On Aug. 22, 2023, the U.S. Department of Health and Human Services (HHS) announced it had awarded more…
-
COVID-19 vaccination and boosting during pregnancy benefits pregnant women and newborns
On Aug. 11, 2023, a study funded by the National Institute of Allergy and Infectious Diseases (NIAID) reported…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Vaccine | WHO
WHO issued standing recommendations for COVID including Omicron EG.5 variant risk
On Aug. 9, 2023, the World Health Organization (WHO) classified the EG.5 coronavirus strain circulating in the United…
-
Scientists developed breath test that rapidly detects COVID-19 virus
On Jul. 31, 2023, scientists at Washington University in St. Louis have developed a breath test that quickly…
-
JAMA reported excess death rates for Republican and Democratic voters in Florida and Ohio during COVID-19 pandemic
On Jul. 24, 2023, the Journal JAMA reported there is evidence that Republican-leaning counties had higher COVID-19 death…
-
U.S. FDA approved Veklury (Remdesivir) for COVID-19 treatment in patients with Severe renal impairment
On Jul. 14, 2023, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) had approved a…
-
CDC launched ‘Bridge Access Program’ to provide free COVID-19 vaccines to uninsured and underinsured adults
On Jul. 13, 2023, the Centers for Disease Control and Prevention (CDC) announced the launch of the Bridge…
-
U.S. FDA updated COVID-19 vaccines for use in the U.S. beginning in Fall 2023
On Jun. 16, 2023, the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee…
-
U.S. FDA permitted marketing of first COVID-19 at-home test using traditional premarket review process
On Jun. 6, 2023, the U.S. Food and Drug Administration (FDA) granted granted marketing authorization for the Cue COVID-19…
-
WHO announced simple, easy-to-say labels for SARS-CoV-2 Variants of Interest and Concern
On May 31, 2023, the World Health Organization (WHO) announced it had assigned simple, easy to say and…
